Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome

Laurent Villard, Marie Claude Bonino, Fatima Abidi, Angela Ragusa, Jérôme Belougne, Anne Marie Lossi, Laurie Seaver, Jean Paul Bonnefont, Corrado Romano, Marco Fichera, Didier Lacombe, André Hanauer, Nicole Philip, Charles Schwartz, Michel Fontés

Research output: Contribution to journalArticle

Abstract

We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.

Original languageEnglish
Pages (from-to)183-186
Number of pages4
JournalJournal of Medical Genetics
Volume36
Issue number3
Publication statusPublished - 1999

Fingerprint

Mutation
Intellectual Disability
Hemoglobin H
Urogenital Abnormalities
Mentally Disabled Persons
Mutation Rate
ATR-X syndrome
RNA
Costs and Cost Analysis
Genes

Keywords

  • ATR-X
  • Mental retardation
  • Mutation
  • Zinc finger

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Villard, L., Bonino, M. C., Abidi, F., Ragusa, A., Belougne, J., Lossi, A. M., ... Fontés, M. (1999). Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. Journal of Medical Genetics, 36(3), 183-186.

Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. / Villard, Laurent; Bonino, Marie Claude; Abidi, Fatima; Ragusa, Angela; Belougne, Jérôme; Lossi, Anne Marie; Seaver, Laurie; Bonnefont, Jean Paul; Romano, Corrado; Fichera, Marco; Lacombe, Didier; Hanauer, André; Philip, Nicole; Schwartz, Charles; Fontés, Michel.

In: Journal of Medical Genetics, Vol. 36, No. 3, 1999, p. 183-186.

Research output: Contribution to journalArticle

Villard, L, Bonino, MC, Abidi, F, Ragusa, A, Belougne, J, Lossi, AM, Seaver, L, Bonnefont, JP, Romano, C, Fichera, M, Lacombe, D, Hanauer, A, Philip, N, Schwartz, C & Fontés, M 1999, 'Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome', Journal of Medical Genetics, vol. 36, no. 3, pp. 183-186.
Villard L, Bonino MC, Abidi F, Ragusa A, Belougne J, Lossi AM et al. Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. Journal of Medical Genetics. 1999;36(3):183-186.
Villard, Laurent ; Bonino, Marie Claude ; Abidi, Fatima ; Ragusa, Angela ; Belougne, Jérôme ; Lossi, Anne Marie ; Seaver, Laurie ; Bonnefont, Jean Paul ; Romano, Corrado ; Fichera, Marco ; Lacombe, Didier ; Hanauer, André ; Philip, Nicole ; Schwartz, Charles ; Fontés, Michel. / Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome. In: Journal of Medical Genetics. 1999 ; Vol. 36, No. 3. pp. 183-186.
@article{02b78bacb7b649a8925f544a95f8d897,
title = "Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome",
abstract = "We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28{\%}. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.",
keywords = "ATR-X, Mental retardation, Mutation, Zinc finger",
author = "Laurent Villard and Bonino, {Marie Claude} and Fatima Abidi and Angela Ragusa and J{\'e}r{\^o}me Belougne and Lossi, {Anne Marie} and Laurie Seaver and Bonnefont, {Jean Paul} and Corrado Romano and Marco Fichera and Didier Lacombe and Andr{\'e} Hanauer and Nicole Philip and Charles Schwartz and Michel Font{\'e}s",
year = "1999",
language = "English",
volume = "36",
pages = "183--186",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome

AU - Villard, Laurent

AU - Bonino, Marie Claude

AU - Abidi, Fatima

AU - Ragusa, Angela

AU - Belougne, Jérôme

AU - Lossi, Anne Marie

AU - Seaver, Laurie

AU - Bonnefont, Jean Paul

AU - Romano, Corrado

AU - Fichera, Marco

AU - Lacombe, Didier

AU - Hanauer, André

AU - Philip, Nicole

AU - Schwartz, Charles

AU - Fontés, Michel

PY - 1999

Y1 - 1999

N2 - We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.

AB - We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.

KW - ATR-X

KW - Mental retardation

KW - Mutation

KW - Zinc finger

UR - http://www.scopus.com/inward/record.url?scp=0033055727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033055727&partnerID=8YFLogxK

M3 - Article

C2 - 10204841

AN - SCOPUS:0033055727

VL - 36

SP - 183

EP - 186

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 3

ER -